Hot Flashes

In addition to a sensation of heat, hot flashes can cause nausea, anxiety, rapid heartbeat, dizziness, and headache. Managing hot flashes can help you maintain your daily activities and improve your quality of life.

Hot flashes at a glance

Hot flashes, also called hot flushes, vasomotor symptoms, or night sweats, are a sensation of your body suddenly feeling hot. Sometimes your skin gets red (flushing) and you may sweat. This can affect your quality of life, work, and sleep.

Cancer treatment and some  medical conditions can make hot flashes worse. Hot flashes from hormone therapy for cancer can be so bothersome that some people stop treatment, which can lead to poorer cancer outcomes. 

The usual—and often most effective—conventional treatment for bothersome hot flashes is to replace estrogen, also called menopausal hormone therapy (MHT). This may not be a safe option for people with hormone-related cancers, but fortunately other options are available. We encourage you to seek help for your hot flashes before they become so bothersome you want to stop treatment.  Including  complementary therapies and lifestyle practices that are known to help hot flashes may improve your well-being and improve your resilience to complete your cancer treatment.

On this page

Hot flashes: an overview

What are hot flashes?

Hot flashes are a sensation of the body suddenly feeling hot. They typically begin with an uneasy feeling, then feeling intensely hot in the face and/or upper body, then feeling hot all over. Before or during a hot flash, you may feel nausea, anxiety, rapid heartbeat, dizziness, and/or headache. You may experience flushing and sweating. They can be a distressing symptom and affect your quality of life, particularly when they interrupt sleep frequently.

Hot flashes are also called hot flushes. They may be called night sweats if they happen at night. Hot flashes and night sweats are also known as vasomotor symptoms.

Hot flashes and cancer

Connections to outcomes among people with cancer 

Side effects of adjuvant hormone therapy such as leuprolide and goserelin, tamoxifen, ovarian suppression analogues, or aromatase inhibitors can become so severe that some people stop treatment, leading to worse cancer outcomes, including poorer survival. Hot flashes are one of the side effects of these treatments.1Zeng E, He W, Smedby KE, Czene K. Adjuvant hormone therapy-related hot flashes predict treatment discontinuation and worse breast cancer prognosis. Journal of the National Comprehensive Cancer Network. 2022 Apr 6;20(6):683-689.e2.

Hot flashes can interfere with the quality of sleep. Reducing the frequency or intensity of hot flashes has led to better sleep outcomes.2Garland SN, Xie SX et al. Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial. Menopause. 2017 May;24(5):517-523. 

What can cause or trigger hot flashes?

Hot flashes are usually caused by hormonal changes. They are common among people with cancer and may be side effects of cancer or treatment including surgery removing gonads, radiation therapy causing ovarian or testicular failure, and medications that suppress ovarian or testicular function.3National Cancer Institute. Hot Flashes and Night Sweats (PDQ®)–Patient Version. July 29, 2021. Viewed October 15, 2024. They are more common in women but also occur in men with locally advanced or metastatic prostate cancer after medical or surgical removal of one or both testicles (orchiectomy).4Charig CR, Rundle JS. Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology. 1989 Mar;33(3):175-8.

Medical conditions

  • Natural menopause

Cancer treatments

  • Tamoxifen
  • Aromatase inhibitors
  • Androgen deprivation therapy (ADT)
  • Gonadotropin-releasing hormones that stop ovaries from producing sex hormones (chemical menopause)

Other medical treatments

  • Surgical menopause from removal of ovaries
  • Surgical removal of one or both testicles (orchiectomy)
  • Opioids
  • Tricyclic antidepressants
  • Steroids

Lifestyle contributors to hot flashes

Evidence links each of these behaviors to increased risk of hot flashes in general, but not specific to people with cancer.6Jenabi E, Poorolajal J. The association between hot flushes and smoking in midlife women: a meta-analysis. Climacteric. 2015;18(6):797-801; Noll PRES, Noll M et al. Life habits of postmenopausal women: association of menopause symptom intensity and food consumption by degree of food processing. Maturitas. 2022 Feb;156:1-11; Gold EB, Flatt SW et al. Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study. Menopause. 2006 May-Jun;13(3):423-33; Stefanopoulou E, Shah D et al. An International Menopause Society study of climate, altitude, temperature (IMS-CAT) and vasomotor symptoms in urban Indian regions. Climacteric. 2014 Aug;17(4):417-24.

  • Smoking cigarettes
  • Eating spicy food
  • Regularly eating ultra-processed food
  • Low intake of vegetables or fiber

Top evidence-based practices and therapies for managing hot flashes

Conventional therapies

Menopausal hormone therapy (MHT), specifically estrogen replacement, effectively controls hot flashes associated with biological or treatment-associated postmenopausal states in women.7Freedman RR, Blacker CM. Estrogen raises the sweating threshold in postmenopausal women with hot flashes. Fertility and Sterility. 2002 Mar;77(3):487-90. However, some hormones, such as estrogen, can make some cancers grow or increase your risk of other cancers, especially breast cancer,8Martin KA, Barbieri RL. Treatment of menopausal symptoms with hormone therapy. UpToDate. November 20, 2023. Viewed October 15, 2024; National Cancer Institute. Hot Flashes and Night Sweats (PDQ®)–Health Professional Version. October 19, 2022. Viewed October 15, 2024; Baber RJ, Panay N, Fenton A; IMS Writing Group. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016 Apr;19(2):109-50; (Holmberg L, Anderson H; HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer—is it safe?), a randomised comparison: trial stopped. Lancet. 2004 Feb 7;363(9407):453-5; Holmberg L, Iversen OE et al; HABITS Study Group. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. Journal of the National Cancer Institute. 2008 Apr 2;100(7):475-82; von Schoultz E, Rutqvist LE; Stockholm Breast Cancer Study Group. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. Journal of the National Cancer Institute. 2005 Apr 6;97(7):533-5. high-risk endometrial cancer, or some types of ovarian cancers. For people with or at high risk of these cancer types, estrogen therapy may be unacceptable (contraindicated). For people with a uterus, progestin therapy is needed to protect the endometrium when estrogen MHT is used. Discuss all the risks and benefits of hormone therapy with your doctor.

The prescription drug gabapentin used “off label” also shows benefits in managing hot flashes among postmenopausal women who are not recommended for hormonal therapy for medical reasons or who prefer alternatives. Use of gabapentin has its own risk of side effects, especially dizziness and unsteadiness.9Yoon SH, Lee JY, Lee C, Lee H, Kim SN. Gabapentin for the treatment of hot flushes in menopause: a meta-analysis. Menopause. 2020 Apr;27(4):485-493. Because any off-label therapies come with side effects, discuss both risks and benefits with your physician.

Medroxyprogesterone acetate (Provera), 5 mg twice daily, appeared to be an effective agent for controlling hot flashes among men after surgical removal of one or both testicles (orchiectomy) in a review.10Charig CR, Rundle JS. Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology. 1989 Mar;33(3):175-8. Hot flashes in men with prostate cancer may also be treated with estrogens, progestin, antidepressants, and anticonvulsants. As with any medications, discuss both risks and benefits with your physician.

Psychosocial counseling (cognitive behavioral therapy) is also used to manage hot flashes and is recommended in clinical practice guidelines.11“The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023 Jun 1;30(6):573-590; Carter J, Lacchetti C et al. Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology clinical practice guideline adaptation of Cancer Care Ontario guideline. Journal of Clinical Oncology. 2018 Feb 10;36(5):492-511; Management of menopausal symptoms in women with a history of breast cancer. Cancer Australia. December 2016. Viewed October 15, 2024.

Helpful links on conventional treatments for hot flashes

Lifestyle practices

These practices have modest, good, or strong evidence of benefit for managing hot flashes, although not always among people with cancer.

These practices have shown benefit among women with menopausal hot flashes, but no research or not enough research has investigated effects among people with cancer.

Complementary therapies 

These therapies have modest, good, or strong evidence of benefit for managing hot flashes among people with cancer.

These therapies have shown benefit among women with menopausal hot flashes, but no research or not enough research has investigated effects among people with cancer.

Recommendation against use; should be avoided

These other complementary therapies are not recommended or have a recommendation against use for managing hot flashes in at least one clinical practice guideline due to a lack of effect in studies:36Greenlee H, DuPont-Reyes MJ et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer Journal for Clinicians. 2017 May 6;67(3):194-232 (this set of guidelines has been endorsed by the American Society of Clinical Oncology (ASCO): Lyman GH, Greenlee H et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. Journal of Clinical Oncology. 2018 Sep 1;36(25):2647-2655); Management of menopausal symptoms in women with a history of breast cancer. Cancer Australia. December 2016. Viewed October 15, 2024; “The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023 Jun 1;30(6):573-590.

  • Angelica sinensis (dong quai)
  • Cannabinoids or cannabis
  • Ginseng
  • Omega-3 fatty acids
  • Paced respiration 
  • Wild yam (Dioscorea barbasco, D. mexicana, or D. villosa)

For professionals  

Practice guidelines for professionals

Recommendations for vasomotor symptoms begin on page 118 (registration with a free account is required.)

Helpful links for professionals

Eden J. Managing menopausal symptoms after breast cancer. European Journal of Endocrinology. 2016 Mar;174(3):R71-7.

Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015 Nov;22(11):1155-72; quiz 1173-4.

Authors

Nancy Hepp, MS

Lead Researcher
View profile

Ms. Hepp is a researcher and communicator who has been writing and editing educational content on varied health topics for more than 20 years. She serves as lead researcher and writer for CancerChoices and also served as the first program manager. Her graduate work in research and cognitive psychology, her master’s degree in instructional design, and her certificate in web design have all guided her in writing and presenting information for a wide variety of audiences and uses. Nancy’s service as faculty development coordinator in the Department of Family Medicine at Wright State University also provided experience in medical research, plus insights into medical education and medical care from the professional’s perspective.

Nancy Hepp, MS Lead Researcher

Laura Pole, MSN, RN, OCNS

Senior Clinical Consultant
View profile

Laura Pole is senior clinical consultant for CancerChoices. Laura is an oncology clinical nurse specialist who has been providing integrative oncology clinical care, navigation, consultation, and education services for over 40 years. She is the co-creator and co-coordinator of the Integrative Oncology Navigation Training at Smith Center for Healing and the Arts in Washington, DC. Laura also manages the “Media Watch Cancer News That You Can Use” listserv for Smith Center/Commonweal. In her role as a palliative care educator and consultant, Laura has served as statewide Respecting Choices Faculty for the Virginia POST (Physician Orders for Scope of Treatment) Collaborative as well as provided statewide professional education on palliative and end-of-life care for the Virginia Association for Hospices and Palliative Care.

For CancerChoices, Laura curates content and research, networks with clinical and organizational partners, brings awareness and education of integrative oncology at professional and patient conferences and programs, and translates research into information relevant to the patient experience as well as clinical practice.

Laura sees her work with CancerChoices as a perfect alignment of all her passions, knowledge and skills in integrative oncology care. She is honored to serve you.

Laura Pole, MSN, RN, OCNS Senior Clinical Consultant

Reviewer

Christine Mineart, MPH

CancerChoices Program Director
View profile

Christine has a dynamic background in the life sciences, public health, and program operations. Her career began at the lab bench with a Gates Foundation-funded HIV Vaccine research group, which led her to graduate studies in public health epidemiology at UC Berkeley. Her research experience spans clinical epidemiology research to evaluating the impacts of community nutrition programs in Los Angeles, the Central Valley, and Oakland. Most recently she has worked in executive operations for a seed-stage venture capital firm based in San Francisco. Personally, Christine is passionate about holistic health and wellness. She is a clinical herbalist and Reiki master, and she has been practicing yoga for 15+ years. She brings a breadth of experiences to her work leading the CancerChoices program.

Christine Mineart, MPH CancerChoices Program Director

Last update: December 17, 2024

Last full literature review: April 2023

CancerChoices provides information about integrativein cancer care, a patient-centered approach combining the best of conventional care, self care, and evidence-informed complementary care in an integrated plan cancer care. We review complementaryin cancer care, complementary care involves the use of therapies intended to enhance or add to standard conventional treatments; examples include supplements, mind-body approaches such as yoga or psychosocialtherapy, and acupuncture therapies and self carelifestyle actions and behaviors that may impact cancer outcomes; examples include eating health-promoting foods, limiting alcohol, increasing physical activity, and managing stress practices to help patients and professionals explore and integrate the best combination of conventionalthe cancer care offered by conventionally trained physicians and most hospitals; examples are chemotherapy, surgery, and radiotherapy and complementary therapies and practices for each person.

Our staff have no financial conflicts of interest to declare. We receive no funds from any manufacturers or retailers gaining financial profit by promoting or discouraging therapies mentioned on this site.

References[+]